[1]
“ Treatment of patients with aortic atherosclerotic disease with paclitaxel-associated lipid nanoparticles ”, Clinics, vol. 71, no. 8, pp. 435–439, Aug. 2016, doi: 10.6061/clinics/2016(08)05.